Filing Details

Accession Number:
0001179110-20-010602
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-20 16:34:17
Reporting Period:
2020-10-16
Accepted Time:
2020-10-20 16:34:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251553 P David Southwell C/o Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-16 15,000 $10.85 16,650 No 4 M Direct
Common Stock Disposition 2020-10-16 14,300 $51.50 2,350 No 4 S Direct
Common Stock Disposition 2020-10-16 700 $52.18 1,650 No 4 S Direct
Common Stock Acquisiton 2020-10-16 12,000 $11.23 13,650 No 4 M Direct
Common Stock Disposition 2020-10-16 11,500 $51.52 2,150 No 4 S Direct
Common Stock Disposition 2020-10-16 500 $52.18 1,650 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-10-16 15,000 $10.85 15,000 $10.85
Common Stock Stock Option (Right to Buy) Disposition 2020-10-16 12,000 $11.23 12,000 $11.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-05-15 No 4 M Direct
0 2027-01-02 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $490.80 2021-04-27 110 110 Direct
Common Stock Stock Option (Right to Buy) $218.40 2022-01-10 110 110 Direct
Common Stock Stock Option (Right to Buy) $27.05 2024-01-28 10,000 10,000 Direct
Common Stock Stock Option (Right to Buy) $51.00 2025-01-02 12,000 12,000 Direct
Common Stock Stock Option (Right to Buy) $30.86 2026-01-03 12,000 12,000 Direct
Common Stock Stock Option (Right to Buy) $18.01 2028-01-02 14,000 14,000 Direct
Common Stock Stock Option (Right to Buy) $33.02 2029-01-02 14,000 14,000 Direct
Common Stock Stock Option (Right to Buy) $51.16 2030-01-28 10,000 10,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-04-27 110 110 Direct
2022-01-10 110 110 Direct
2024-01-28 10,000 10,000 Direct
2025-01-02 12,000 12,000 Direct
2026-01-03 12,000 12,000 Direct
2028-01-02 14,000 14,000 Direct
2029-01-02 14,000 14,000 Direct
2030-01-28 10,000 10,000 Direct
Footnotes
  1. This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2020.
  2. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.12 to $52.09 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.16 to $52.21 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  4. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.10 to $52.09 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  5. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.14 to $52.21 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  6. Currently exercisable.
  7. This option was granted on January 29, 2020 and vests over one year in twelve equal monthly installments, commencing on February 29, 2020.